The role of SOX9 transcription factor in pancreatic and duodenal development

Stem Cells and Development

Volumn 22, Issue 22, 2013, Pages 2935-2943

  Belo, Jamie ^a   Krishnamurthy, Mansa ^a   Oakie, Amanda ^a,b   Wang, Rennian ^a,b,c  

^a The Children's Health Research Institute   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Victoria Research Laboratories   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; NOTCH RECEPTOR; TRANSCRIPTION FACTOR SOX9; WNT PROTEIN; WNT3 PROTEIN;

CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; DUODENUM; ENTEROENDOCRINE CELL; EPITHELIUM CELL; HUMAN; IN VITRO STUDY; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL NICHE; WNT SIGNALING PATHWAY;

CELL DIFFERENTIATION; CELL PROLIFERATION; DUODENUM; ENTEROENDOCRINE CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MORPHOGENESIS; ORGAN SIZE; PANCREAS; PANETH CELLS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; STEM CELLS; WNT PROTEINS;

EID: 84888051783     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0106     Document Type: Review

References (80)

1. Ryan EA, BW Paty, PA Senior, D Bigam, E Alfadhli, NM Kneteman, JRT Lakey and AMJ Shapiro (2005). Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069.
2. Shapiro AM, JR Lakey, EA Ryan, GS Korbutt, E Toth, GL Warnock, NM Kneteman and RV Rajotte (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238.
3. Seymour PA, KK Freude, MN Tran, EE Mayes, J Jensen, R Kist, G Scherer and M Sander. (2007). SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci U S A 104:1865-1870.
4. Seymour PA, KK Freude, CL Dubois, HP Shih, NA Patel and M Sander. (2008). A dosage-dependent requirement for Sox9 in pancreatic endocrine cell formation. Dev Biol 323:19-30.
5. Bastide P, C Darido, J Pannequin, R Kist, S Robine, C Marty-Double, F Bibeau, G Scherer, D Joubert, et al. (2007). Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 178:635-648.
6. Formeister EJ, AL Sionas, DK Lorance, CL Barkley, GH Lee and ST Magness. (2009). Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. Am J Physiol Gastrointest Liver Physiol 296:G1108-G1118.
7. Lynn FC, SB Smith, ME Wilson, KY Yang, N Nekrep and MS German. (2007). Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A 104:10500-10505.
8. Weiss MA. (2001). Floppy SOX: mutual induced fit in hmg (high-mobility group) box-DNA recognition. Mol Endocrinol 15:353-362.
9. Wegner M. (1999). From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27:1409-1420.
10. van de Wetering M and H Clevers. (1992). Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix. Embo J 11:3039-3044.
11. Laudet V, D Stehelin and H Clevers. (1993). Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res 21:2493-2501.
12. Prior HM and MA Walter. (1996). SOX genes: architects of development. Mol Med 2:405-412.
13. Bernard P and VR Harley. (2010). Acquisition of SOX transcription factor specificity through protein-protein interaction, modulation of Wnt signalling and post-translational modification. Int J Biochem Cell Biol 42:400-410.
14. Pritchett J, V Athwal, N Roberts, NA Hanley and KP Hanley. (2011). Understanding the role of SOX9 in acquired diseases: lessons from development. Trends Mol Med 17:166-174.
15. Kondoh H and Y Kamachi. (2010). SOX-partner code for cell specification: regulatory target selection and underlying molecular mechanisms. Int J Biochem Cell Biol 42:391-399.
16. Kamachi Y, M Uchikawa and H Kondoh. (2000). Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 16:182-187.
17. Piper K, SG Ball, JW Keeling, S Mansoor, DI Wilson and NA Hanley. (2002). Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. Mech Dev 116:223-226.
18. Bi W, W Huang, DJ Whitworth, JM Deng, Z Zhang, RR Behringer and B de Crombrugghe. (2001). Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A 98:6698-6703.
19. Gordon CT, TY Tan, S Benko, D Fitzpatrick, S Lyonnet and PG Farlie. (2009). Long-range regulation at the SOX9 locus in development and disease. J Med Genet 46:649-656.
20. Foster JW, MA Dominguez-Steglich, S Guioli, C Kwok, PA Weller, M Stevanovic, J Weissenbach, S Mansour, ID Young and PN Goodfellow. (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
21. Wagner T, J Wirth, J Meyer, B Zabel, M Held, J Zimmer, J Pasantes, FD Bricarelli, J Keutel, et al. (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120.
22. Mori-Akiyama Y, M van den Born, JH van Es, SR Hamilton, HP Adams, J Zhang, H Clevers and B de Crombrugghe. (2007). SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 133:539-546.
23. Hanley KP, F Oakley, S Sugden, DI Wilson, DA Mann and NA Hanley. (2008). Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 283:14063-14071.
24. de Santa Barbara P, N Bonneaud, B Boizet, M Desclozeaux, B Moniot, P Sudbeck, G Scherer, F Poulat and P Berta. (1998). Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol Cell Biol 18:6653-6665.
25. Bagheri-Fam S, F Barrionuevo, U Dohrmann, T Günther, R Schüle, R Kemler, M Mallo, B Kanzler and G Scherer. (2006). Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern. Dev Biol 291:382-397.
26. Mead TJ, Q Wang, P Bhattaram, P Dy, S Afelik, J Jensen and V Lefebvre. (2013). A far-upstream (- 70 kb) enhancer mediates Sox9 auto-regulation in somatic tissues during development and adult regeneration. Nucleic Acids Res 41:4459-4469.
27. Blache P, M van de Wetering, I Duluc, C Domon, P Berta, J-N Freund, H Clevers and P Jay. (2004). SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 166:37-47.
28. Akiyama H, JP Lyons, Y Mori-Akiyama, X Yang, R Zhang, Z Zhang, JM Deng, MM Taketo, T Nakamura, et al. (2004). Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087.
29. Yano F, F Kugimiya, S Ohba, T Ikeda, H Chikuda, T Ogasawara, N Ogata, T Takato, K Nakamura, H Kawaguchi and U-I Chung. (2005). The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem Biophys Res Commun 333:1300-1308.
30. Topol L, W Chen, H Song, TF Day and Y Yang. (2009). Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 284:3323-3333.
31. Slack JM. (1995). Developmental biology of the pancreas. Development 121:1569-1580.
32. Zorn AM and JM Wells. (2009). Vertebrate endoderm development and organ formation. Annu Rev Cell Dev Biol 25:221-251.
33. Lewis SL and PPL Tam. (2006). Definitive endoderm of the mouse embryo: formation, cell fates, and morphogenetic function. Dev Dyn 235:2315-2329.
34. Guz Y, MR Montminy, R Stein, J Leonard, LW Gamer, CV Wright and G Teitelman. (1995). Expression of murine STF- 1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121:11-18.
35. Furuyama K, Y Kawaguchi, H Akiyama, M Horiguchi, S Kodama, T Kuhara, S Hosokawa, A Elbahrawy, T Soeda, et al. (2011). Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43:34-41.
36. Lioubinski O, M Müller, M Wegner and M Sander. (2003). Expression of Sox transcription factors in the developing mouse pancreas. Dev Dyn 227:402-408.
37. Apelqvist A, H Li, L Sommer, P Beatus, DJ Anderson, T Honjo, M Hrabe de Angelis, U Lendahl and H Edlund. (1999). Notch signalling controls pancreatic cell differentiation. Nature 400:877-881.
38. Jensen J, EE Pedersen, P Galante, J Hald, RS Heller, M Ishibashi, R Kageyama, F Guillemot, P Serup and OD Madsen. (2000). Control of endodermal endocrine development by Hes-1. Nat Genet 24:36-44.
39. Seymour PA, HP Shih, NA Patell, KK Freude, R Xiel, CJ Lim and M Sander. (2012). A Sox9/Fgf feed-forward loop maintains pancreatic organ identity. Development 139:3363-3372.
40. Dubois CL, HP Shih, PA Seymour, NA Patel, JM Behrmann, V Ngo and M Sander. (2011). Sox9-haploinsufficiency causes glucose intolerance in mice. PLoS One 6:e23131.
41. Pan FC, ED Bankaitis, D Boyer, X Xu, M Van de Casteele, MA Magnuson, H Heimberg and CV Wright. (2013). Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration. Development 140:751-764.
42. McDonald E, J Li, M Krishnamurthy, GF Fellows, CG Goodyer and R Wang. (2012). SOX9 regulates endocrine cell differentiation during human fetal pancreas development. Int J Biochem Cell Biol 44:72-83.
43. Piper K, S Brickwood, LW Turnpenny, IT Cameron, SG Ball, DI Wilson and NA Hanley. (2004). Beta cell differentiation during early human pancreas development. J Endocrinol 181:11-23.
44. Gu G, J Dubauskaite and DA Melton. (2002). Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129:2447-2457.
45. de Santa Barbara P, GR van den Brink and DJ Roberts. (2003). Development and differentiation of the intestinal epithelium. Cell Mol Life Sci 60:1322-1332.
46. Stappenbeck TS, MH Wong, JR Saam, IU Mysorekar and JI Gordon. (1998). Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium. Curr Opin Cell Biol 10:702-709.
47. Gracz AD and ST Magness. (2011). Sry-box (Sox) transcription factors in gastrointestinal physiology and disease. Am J Physiol Gastroint Liver Physiol 300:G503-G515.
48. Fre S, M Huyghe, P Mourikis, S Robine, D Louvard and S Artavanis-Tsakonas. (2005). Notch signals control the fate of immature progenitor cells in the intestine. Nature 435:964-968.
49. van Es JH, ME van Gijn, O Riccio, M van den Born, M Vooijs, H Begthel, M Cozijnsen, S Robine, DJ Winton, F Radtke and H Clevers. (2005). Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435:959-963.
50. Yang Q, NA Bermingham, MJ Finegold and HY Zoghbi. (2001). Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294:2155-2158.
51. Gerbe F, JH van Es, L Makrini, B Brulin, G Mellitzer, S Robine, B Romagnolo, NF Shroyer, J-F Bourgaux, et al. (2011). Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J Cell Biol 192:767-780.
52. Lammert E, J Brown and DA Melton. (2000). Notch gene expression during pancreatic organogenesis. Mech Dev 94:199-203.
53. Artavanis-Tsakonas S, MD Rand and RJ Lake. (1999). Notch signaling: cell fate control and signal integration in development. Science 284:770-776.
54. Ehebauer M, P Hayward and AM Arias. (2006). Notch, a universal arbiter of cell fate decisions. Science 314:1414-1415.
55. Shih HP, JL Kopp, M Sandhu, CL Dubois, PA Seymour, A Grapin-Botton and M Sander. (2012). A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation. Development 139:2488-2499.
56. Nusse R, C Fuerer, W Ching, K Harnish, C Logan, A Zeng, D ten Berge and Y Kalani. (2008). Wnt signaling and stem cell control. Cold Spring Harb Symp Quant Biol 73:59-66.
57. Ling L, V Nurcombe and SM Cool. (2009). Wnt signaling controls the fate of mesenchymal stem cells. Gene 433:1-7.
58. Katoh M. (2007). WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13:4042-4045.
59. Dravid G, Z Ye, H Hammond, G Chen, A Pyle, P Donovan, X Yu and L Cheng. (2005). Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 23:1489-1501.
60. Kalani MY, SH Cheshier, BJ Cord, SR Bababeygy, H Vogel, IL Weissman, TD Palmer and R Nusse. (2008). Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A 105:16970-16975.
61. Willert K, JD Brown, E Danenberg, AW Duncan, IL Weissman, T Reya, JR Yates and R Nusse. (2003). Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448-452.
62. Akiyama H. (2008). Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 18:213-219.
63. van Amerongen R and R Nusse. (2009). Towards an integrated view of Wnt signaling in development. Development 136:3205-3214.
64. MacDonald BT, K Tamai and X He. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9-26.
65. Clevers H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127:469-480.
66. Li C, H Chen, L Hu, Y Xing, T Sasaki, MF Villosis, J Li, M Nishita, Y Minami and P Minoo. (2008). Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2. BMC Mol Biol 9:11.
67. Mikels AJ and R Nusse. (2006). Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115.
68. Grumolato L, G Liu, P Mong, R Mudbhary, R Biswas, R Arroyave, S Vijayakumar, AN Economides and SA Aaronson. (2010). Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24:2517-2530.
69. Hill TP, D Später, MM Taketo, W Birchmeier and C Hartmann. (2005). Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738.
70. Korinek V, N Barker, PJ Morin, D van Wichen, R de Weger, KW Kinzler, B Vogelstein and H Clevers. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784-1787.
71. Powell SM, N Zilz, Y Beazer-Barclay, TM Bryan, SR Hamilton, SN Thibodeau, B Vogelstein and KW Kinzler. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237.
72. van de Wetering M, E Sancho, C Verweij, Wde Lau, I Oving, A Hurlstone, K van der Horn, E Batlle, D Coudreuse, et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241-250.
73. Batlle E, JT Henderson, H Beghtel, MMW van den Born, E Sancho, G Huls, J Meeldijk, J Robertson, M van de Wetering, T Pawson and H Clevers. (2002). Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111:251-263.
74. Korinek V, N Barker, P Moerer, E van Donselaar, G Huls, PJ Peters and H Clevers. (1998). Depletion of epithelial stemcell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19:379-383.
75. Sato T, JH van Es, HJ Snippert, DE Stange, RG Vries, M van den Born, N Barker, NF Shroyer, M van de Wetering and H Clevers. (2011). Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469:415-418.
76. Cossais F, M Wahlbuhl, J Kriesch and M Wegner. (2010). SOX10 structure-function analysis in the chicken neural tube reveals important insights into its role in human neurocristopathies. Hum Mol Genet 19:2409-2420.
77. Sim H, A Argentaro and VR Harley. (2008). Boys, girls and shuttling of SRY and SOX9. Trends Endocrinol Metab 19:213-222.
78. Smith JM and PA Koopman. (2004). The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease. Trends Genet 20:4-8.
79. Staffler A, M Hammel, M Wahlbuhl, C Bidlingmaier, AW Flemmer, P Pagel, T Nicolai, M Wegner and A Holzinger. (2010). Heterozygous SOX9 mutations allowing for residual DNA-binding and transcriptional activation lead to the acampomelic variant of campomelic dysplasia. Hum Mutat 31:E1436-E1444.
80. Sudbeck P, ML Schmitz, PA Baeuerle and G Scherer. (1996). Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat Genet 13:230-232.